Author

Phillip L. Campbell

University of Michigan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Christopher D. SchareriD· 1 shared David A. FoxiD· 1 shared Dean E. Draayer· 1 shared Deanna DwyeriD· 1 shared Elizabeth Anne MillsiD· 1 shared Jeremy M. BossiD· 1 shared Joshua S MytychiD· 1 shared Joshua W. GartoniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Christopher D. ScharerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Ocrelizumab Modulates Both B and T Cell Immune Capacities in Multiple Sclerosis

Qi Wu, Mikel Gurrea‐Rubio, Q. Wang, Deanna Dwyer, Elizabeth Anne Mills, Joshua W. Garton, Joshua S Mytych, Steven K. Lundy, Christopher D. Scharer, Jeremy M. Boss, Laura A. Cooney, Dean E. Draayer, Phillip L. Campbell, David A. Fox, Yang Mao‐Draayer

This study examines how ocrelizumab affects B and T cell populations in MS patients, revealing changes in B cell subsets and T cell dynamics, along with altered signaling pathways.

bioRxiv · Mar 26, 2026 · PreprintImmunology